Court reverses Risperdal decision

Share this article:

The Arkansas Supreme Court has put $1.2 billion into Johnson & Johnson's accounts.

The court ruled last week that a previous ruling, which slapped the drugmaker for violating Medicaid fraud and deceptive marketing practices, was erroneous because the wrong standard was used.

As explained by Reuters, the court reversed the financial penalty because the court said plaintiffs invoked a law that applies to healthcare facilities, as opposed to a corporation.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M inVISION